Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
Go back to Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program| (NASDAQ: ASMB) | Delayed: 29.80 -0.66 (2.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.46 | 52 Week High | $14.50 | |||
| Open | $30.83 | 52 Week Low | $4.33 | |||
| Day High | $31.72 | P/E | N/A | |||
| Day Low | $29.68 | EPS | $0.00 | |||
| Volume | 258,946 | |||||

